-
NEWS
BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT TrialBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a significant milestone in its advanced tissue regeneration strategy: the first Phasix™...
-
NEWS
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow CytometryBD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person Immune Profiling Study FRANKLIN...
-
BLOG
Expanded Access Brings Expanded OptionsReducing access barriers for hernia patients nationwide